Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 334 · FY2023 643 · FY2024 19 — 3-yr total 996
Georgian medical diagnostic / laboratory services company affiliated with the international Human Diagnostic network.
Group parent — controls 1 company · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 8,727 | 812 | 2,206 | 2,798 | 2,009 | 174 | 1,956 | -22.1% |
| Net Cash used in Investing Activities | 0 | 405 | 1,655 | 903 | 1,951 | 611 | 1,914 | nmf |
| Free Cash Flow (OCF − Capex proxy) | 8,727 | 407 | 551 | 1,895 | 58 | 786 | 42 | nmf |
| Net Cash from Financing Activities | 8,838 | 204 | 388 | 927 | 0 | 341 | 207 | -46.5% |
| Net Change in Cash (before FX) | 112 | 203 | 163 | 968 | 58 | 444 | 165 | +6.8% |
| Effect of FX on Cash | 1 | 14 | 208 | 135 | 233 | 10 | 44 | +86.0% |
| Net Change in Cash (incl. FX) | 113 | 188 | 45 | 833 | 175 | 434 | 209 | +10.9% |
| Cash at Beginning of Year | 179 | 66 | 254 | 210 | 1,043 | 868 | 434 | +15.9% |
| Cash at End of Year | 66 | 254 | 210 | 1,043 | 868 | 434 | 224 | +22.5% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.